Yale University

Affiliated Projects

Project Titlesort icon Principal Investigator(s) Funder Project Period Start Project Period End Funding Mechanism Further Detail
1 Zero Tolerance: The Impact of Eviction on Health and HIV-Related Risk Behaviors Sonja Plesset, Ph.D. CIRA 02/13/2004 02/12/2006 CIRA Pilot
2 Yale AITRP: Supplement for Nicaragua Fogarty International Center 09/22/2004 05/31/2009
3 Working with HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation (What If?) David A. Fiellin, M.D. National Institute on Drug Abuse 09/30/2015 05/31/2017 R01 Further Detail
4 Women's Sexual Behavior in the Context of Injection Drug Use Kim M. Blankenship, Ph.D. CIRA 06/30/1999 02/28/2005 CIRA Pilot
5 With an Eye to the Law: Providing Client-Centered Care in the Shadow of Criminal Prosecution for HIV Exposure Robert Wood Johnson Foundation 04/01/2013 03/31/2015
6 With an Eye to the Law: Providing Client-Centered Care in the Shadow of Criminal Prosecution for HIV Exposure Robert Wood Johnson Foundation 04/01/2013 03/31/2015
7 Wise Women Win: Mentoring by and for Mature Women for HIV/STD Prevention Linda Niccolai, Ph.D. CIRA 05/02/2006 04/30/2008 CRPP
8 Wise Women Win: Mentoring by and for Mature Women for HIV/STD Prevention Nicholas Boshnack, M.S.W. CIRA 05/02/2006 04/30/2008 CRPP
9 Who's On Board: Parent, Child, and Provider Attitudes towards the Feasibility of PrEP Uptake among Adolescents National Institute of Mental Health 07/31/2017 07/12/2018 CIRA Pilot Project
10 Who's On Board: Parent, Child, and Provider Attitudes towards the Feasibility of PrEP Uptake among Adolescents Tashuna Albritton, Ph.D. National Institute of Mental Health 07/31/2017 07/12/2018 CIRA Pilot Project
11 What We Can Learn About the Introduction and Acceptance of the Female Condom Through International Example Laurie Sylla, B.S.W, M.H.S.A. CIRA 05/10/2002 05/09/2003
12 What They're Not Telling Me: Veterans, Trust, and HIV Care in the VA amfAR 08/01/2008 08/01/2010
13 Vulnerability for Drug Abuse in Children (Supplement) Kathleen R. Merikangas, Ph.D. National Institute on Drug Abuse 06/01/1995 05/31/2000 R01 Further Detail
14 Vulnerability for Drug Abuse in Children Kathleen R. Merikangas, Ph.D. National Institute on Drug Abuse 06/01/1995 05/31/2000 R01 Further Detail
15 Utilizing Social Technologies and Social Networks to Increase HIV Testing among Men Who Have Sex with Men in Connecticut Trace Kershaw, Ph.D. CIRA 08/28/2012 08/27/2013 CIRA Pilot Project
16 Using Web-based Peer Support to Increase HIV Testing Among Men who have Sex with Men in Kenya DeAnne Turner, Ph.D., M.P.H. National Institute of Mental Health CIRA Pilot Project
17 Using the VACS Index to Track Health Outcomes Associated with Changes in Drug Use David A. Fiellin, M.D. NIDA 04/01/2013 02/28/2017 R01 Further Detail
18 Using the VACS Index to Track Health Outcomes Associated with Changes in Drug Use Amy C. Justice, M.D., M.Sc., Ph.D. NIDA 04/01/2013 02/28/2017 R01 Further Detail
19 Using Smart Phones to Understand the Link Between Social and Geographical Context and HIV Risk Behavior Among MSM Trace Kershaw, Ph.D. National Institute of Child Health and Human Development 09/01/2017 04/30/2022 R01 Further Detail
20 Using Smart Phones to Understand the Link Between Social and Geographical Context and HIV Risk Behavior Among MSM Nathan B Hansen, Ph.D. National Institute of Child Health and Human Development 09/01/2017 04/30/2022 R01 Further Detail
21 Using EMA to Assess the PTSD-HIV Risk Behavior Relationship in OEF/OIF Veterans National Institute on Drug Abuse 02/15/2015 01/31/2017 R21 Further Detail
22 Using Cell Phones to Understand Social Networks of Young Men Trace Kershaw, Ph.D. National Institute on Drug Abuse 06/01/2012 05/31/2015 R21 Further Detail
23 Unmet Mental Health Care Needs of Patients in an HIV Specialty Clinic Lydia Chwastiak, M.D.,M.P.H CIRA 06/04/2004 06/03/2005 CIRA Pilot
24 Understanding the Social and Psychological Context of Acute Infection: Yale-Brown Collaboration Paul D. Cleary, Ph.D. National Institute of Mental Health 09/30/2001 02/28/2007
25 Understanding the Role of Neighborhoods on Urban Youth's Substance Use and Mental Health: A Community-Based Substance Abuse Prevention Project Ijeoma Opara, PhD, LMSW, MPH Office of the Director, National Institutes of Health 07/01/2021 08/31/2025 DP5 Further Detail
26 Understanding the impact of COVID-19 on individuals with HIV with tobacco use: A mixed-methods Study E. Jennifer Edelman, MD, MHS, BS National Institute of Mental Health 06/08/2020 06/07/2021 CIRA Pilot Project
27 Understanding Self and Family Management in HIV-Positive Asian Americans in New York Wei-Ti Chen, Ph.D. National Institute on Minority Health and Health Disparities 08/15/2017 04/30/2019 R03 Further Detail
28 Understanding Relapse and the Impact of Social Networks and Geographic Settings During Treatment for Alcohol-Related Problems Trace Kershaw, Ph.D. National Institute on Alcohol Abuse and Alcoholism 09/20/2018 08/31/2023 R01 Further Detail
29 Understanding Black Women's Experiences of Sexual Satisfaction to Inform HIV Prevention Jasmine Abrams, Ph.D. National Institute of Mental Health 07/11/2017 07/10/2018 REIDS Pilot Project
30 Translation of the Risk Avoidance Partnership (RAP) for Drug Treatment Clinic Implementation Margaret R. Weeks, Ph.D. National Institute on Drug Abuse 09/15/2010 08/31/2013 R34 Further Detail
31 Training in Nursing Interventions for HIV and Addiction in Criminal Justice Settings Gabriel John Culbert, Ph.D. National Institute on Drug Abuse 09/01/2017 08/31/2021 K23 Further Detail
32 Training in HIV Prevention & Care Research in South Africa-ICOHRTA Kari Hartwig, Dr. P.H., M.A. Fogarty International Center/National Institute on Drug Abuse 09/27/2001 09/30/2007
33 Training in Drug Abuse & HIV Prevention for Female & Transgender Sex Workers Jeffrey A. Wickersham, Ph.D. National Institute on Drug Abuse 07/01/2014 06/30/2019 K01 Further Detail
34 Training and Research in HIV Prevention in Russia Robert Heimer, Ph.D. Fogarty International Center 09/30/1998 04/30/2017 D43 Further Detail
35 Toll-Like Receptor Ligands as Microbicide for Sexually Transmitted Viruses Akiko Iwasaki, Ph.D. CIRA 02/09/2004 02/08/2005 CIRA Pilot
36 The Social Context of Sexual Behavior and HIV Transmission in an Agricultural Plantation Community: An Ethnographic and Epidemiological Study of Sugar Estate Workers in Northern Tanzania Eric Worby, Ph.D. CIRA 04/01/2002 03/31/2003 CIRA Pilot
37 The Role of Folk Remedies including Traditional Medicine for Sexually Transmitted Infection Treatment in Sub-Saharan Africa Linda Niccolai, Ph.D. CIRA 10/01/2003 09/30/2004
38 The Role of Casual Contact and Migration in XDR TB Transmission in South Africa: A Geospatial, Genomic and Social Network Study Ted Cohen, M.D.,M.P.H National Institute of Allergy and Infectious Diseases 01/17/2018 12/31/2022 R01 Further Detail
39 The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment David A. Fiellin, M.D. CIRA 08/23/2007 12/31/2010 CIRA Pilot
40 The Influence of Peer Social Networks on Sexual Risk and Service Utilization among Young Fathers Trace Kershaw, Ph.D. CIRA 06/27/2011 06/26/2012 CRPP
41 The Influence of Peer Social Networks on Sexual Risk and Service Utilization among Young Fathers CIRA 06/27/2011 06/26/2012 CRPP
42 The Impact of Individual- and Neighborhood-Level Social Connectedness on Mental Health in Black Adults Yusuf Ransome, MPH, DrPH National Institute on Minority Health and Health Disparities 07/15/2023 12/31/2026 R01 Further Detail
43 The Impact of Incarceration On the Continuity of HIV Care in Connecticut National Institute on Drug Abuse 04/16/2016 04/15/2019 F30 Further Detail
44 The Impact of Incarceration and Substance Abuse on HIV-Infected Veterans National Institute on Drug Abuse 06/01/2012 05/31/2016 R03 Further Detail
45 The Impact of HIV/AIDS on Disabled Populations: Policy Interventions Nora Ellen Groce, Ph.D. International Labor Organization 01/01/2006 12/31/2006
46 The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction Sandra Ann Springer, M.D. National Institute on Drug Abuse 09/01/2016 05/31/2021 R01 Further Detail
47 The Impact of Health System Factors on HIV/AIDS Prevention and Treatment in Poor Rural China Hong Wang, Ph.D. CIRA 07/07/2005 07/06/2006 CIRA Pilot
48 The Impact of Compliance with the WTO Trade Related Aspects of Intellectual Property (TRIPS) Agreement on Access to HIV/AIDS Medicines in India and Other Low and Middle Income Countries Amy Kapczynski, J.D. CIRA 07/19/2006 07/18/2008 CIRA Pilot
49 The HIV and Alcohol Research center focused on Polypharmacy (HARP) Amy C. Justice, M.D., M.Sc., Ph.D. National Institute on Alcohol Abuse and Alcoholism 09/10/2021 08/31/2026 P01 Further Detail
50 The Effects of HIV Disease in Pregnancy on the Development of Uninfected Children: an Exploratory Study to Understand Possible Mechanisms Albert McKern Trust Fund 02/15/2012 02/15/2014
51 The Context of HIV Testing for Detection of Early HIV Infection in St. Petersburg Linda Niccolai, Ph.D. CIRA 10/01/2007 06/30/2009 CIRA Pilot
52 The Classification of Government HIV/AIDS Prevention Regimes: A Cross-National Pilot Study Evan Lieberman, Ph.D. CIRA 09/01/2001 07/31/2003 CIRA Pilot
53 Testing a Biopsychosocial Model of Violence Exposure, Minority Stressors, and Hazardous Drinking among Sexual Minority Women Jillian R. Scheer, Ph.D. National Institute on Alcohol Abuse and Alcoholism 06/01/2021 05/31/2026 K01 Further Detail
54 Test and Linkage to Care (TLC-IDU) Kenya Ann Kurth, Ph.D., CNM, MPH National Institute on Drug Abuse 01/01/2016 04/30/2017 R01 Further Detail
55 TB and Other Pulmonary Complications of AIDS Research Training Program Luke Davis, M.D. Fogarty International Center 08/01/2013 03/31/2023 D43 Further Detail
56 Syringe Exchange Based Hepatitis B Vaccination of IDUs Robert Heimer, Ph.D. National Institute on Drug Abuse 03/01/2003 02/28/2007 R01 Further Detail
57 Syringe Access and HIV Risk National Institute on Drug Abuse 05/05/1999 04/30/2003 R01 Further Detail
58 Sustained Safe Behavior in High-Risk Women Margaret R. Weeks, Ph.D. National Institute of Mental Health 02/06/2004 01/31/2008 R01 Further Detail
59 Supportive Housing for PLHA: Risk Behaviors and Prevention Interventions Kim M. Blankenship, Ph.D. CIRA 07/17/2007 07/16/2009 CRPP
60 Supportive Housing for PLHA: Risk Behaviors and Prevention Interventions CIRA 07/17/2007 07/16/2009 CRPP
61 Substance Use and Other Situational Factors Impacting Sexual Risk-Taking among HIV-Positive Men who have Sex with Men (MSM) CIRA 02/18/2005 02/28/2009 CIRA Pilot
62 Study of Research Ethics with Active Users of Illicit Drugs Kaveh Khoshnood, Ph.D., M.P.H. Donaghue Foundation 01/01/2004 12/31/2006
63 Structural Stigma and HIV Risk in a Representative Cohort of Gay and Bisexual Men John Pachankis, Ph.D. National Institute of Mental Health 07/19/2017 04/30/2022 R01 Further Detail
64 Structural Stigma and HIV Risk in a Representative Cohort of Gay and Bisexual Men Mark Hatzenbuehler, Ph.D. National Institute of Mental Health 07/19/2017 04/30/2022 R01 Further Detail
65 Structural Interventions to Reduce HIV Incidence in Drug Users Kim M. Blankenship, Ph.D. Centers for Disease Control 09/30/1999 09/29/2002
66 Structural Interventions and Women's Risk for HIV: Is There Evidence of Lessons Learned from "Successful" Country HIV/AIDS Programs? Kari Hartwig, Dr. P.H., M.A. CIRA 10/12/2004 04/11/2006
67 Structural and Policy Factors in Black-White Disparities in HIV/AIDS Michael H. Merson, M.D. Office of AIDS Research 09/01/2002 02/28/2005
68 Stigma, Romantic Relationships, and Alcohol Use Among Transgender and Nonbinary Young Adults Gabe Murchison, Ph.D., M.P.H. National Institute on Alcohol Abuse and Alcoholism 02/25/2023 01/31/2025 K99 Further Detail
69 St. Louis Enhancing Engagement and Retention in HIV/AIDS Care (STEER) Trace Kershaw, Ph.D. National Institute of Mental Health 09/30/2021 02/28/2023 P30 Further Detail
70 St. Louis Enhancing Engagement and Retention in HIV/AIDS Care (STEER) Debbie Humphries, Ph.D., M.P.H. National Institute of Mental Health 09/30/2021 02/28/2023 P30 Further Detail
71 Sociocultural Factors on Syringe Sharing and HIV Risks JiangHong Li, M.D., M.Sc. National Institute on Drug Abuse 09/30/2001 08/31/2004 R03 Further Detail
72 Social Determinants of HIV: The Intersecting Impacts of Mass Incarceration, Housing Stability, and Subsidized Housing Policies Kim M. Blankenship, Ph.D. National Institute of Mental Health 06/15/2016 03/31/2017 RO1 Further Detail
73 Social Determinants of HIV: The Intersecting Impacts of Mass Incarceration, Housing Stability, and Subsidized Housing Policies Linda Niccolai, Ph.D. National Institute of Mental Health 06/15/2016 03/31/2017 RO1 Further Detail
74 Social Capital and Late HIV Diagnosis in the United States Yusuf Ransome, MPH, DrPH National Institute of Mental Health 04/06/2017 03/31/2022 K01 Further Detail
75 Simulating HIV-1 Transmission Risks among IDUs Robert Heimer, Ph.D. National Institute on Drug Abuse 06/15/1996 12/31/2002 R01 Further Detail
76 She's PrEPared: The Impact of Intimate Partner Violence on Women's Engagement in the PrEP Care Continuum Tiara C. Willie, Ph.D. National Institute of Mental Health 09/01/2017 08/31/2019 F31 Further Detail
77 Sexual Partnership Characteristics, Patterns, and Condom Use Among Persons Infected With HIV Linda Niccolai, Ph.D. CIRA 04/15/2002 04/14/2003 CIRA Pilot
78 Serosorting Intervention for HIV Negative MSM National Institute of Mental Health 07/11/2011 04/30/2016 R01 Further Detail
79 Self- and Family-Management Intervention in HIV+ Chinese Women Wei-Ti Chen, Ph.D. National Institute of Nursing Research 05/16/2013 04/30/2016 K23 Further Detail
80 Safety and Comparative Effectiveness of New Medications for Unhealthy Alcohol Use in HIV David A. Fiellin, M.D. National Institute on Alcohol Abuse and Alcoholism 02/15/2015 01/31/2018 R01 Further Detail
81 Role of Emotional Distress and Suicidality in HIV/AIDS-Related Risky Sexual Behavior During Adolescence Golan Shahar, Ph.D. CIRA 04/16/2003 04/15/2005 CIRA Pilot
82 Risk patterns of Latino/a Emergent Adult Sexual Networks CIRA 09/15/2011 09/14/2012 CRPP
83 Risk patterns of Latino/a Emergent Adult Sexual Networks Cándida Flores CIRA 09/15/2011 09/14/2012 CRPP
84 Risk in Partnerships for Repeat Sexually Transmitted Infection Linda Niccolai, Ph.D. Donaghue Foundation 01/01/2005 12/31/2008
85 Risk Behavior and Functioning in HIV-Affected Adolescents Robert A. Murphy, Ph.D. CIRA 09/01/1999 08/31/2000 CIRA Pilot
86 Risk Assessment of STDs Among IDUs in Russia CIRA 02/01/2001 07/31/2008 CIRA Pilot
87 Research Training in HIV-Associated Cancer Genomics Fogarty International Center 10/01/2007 05/31/2010 D43
88 Research Ethics Training and Curriculum Development Program with China Kaveh Khoshnood, Ph.D., M.P.H. Fogarty International Center 06/01/2011 05/31/2017 R25 Further Detail
89 Research Ethics in Cross-Cultural HIV/AIDS Studies with Active Users of Illicit Drugs Kaveh Khoshnood, Ph.D., M.P.H. CIRA 10/01/2003 09/30/2004
90 Research Education Institute for Diverse Scholars (REIDS) Trace Kershaw, Ph.D. National Institute of Mental Health 09/01/2015 05/31/2020 R25 Further Detail
91 Reduction of Gender-Based Violence in Rural Cote d’Ivoire The World Bank 09/01/2010 05/31/2013
92 Reducing Violence and HIV Risk among War-Exposed Liberian Youth Nathan Hansen, Ph.D. National Institute of Mental Health 07/13/2011 06/30/2016 R34 Further Detail
93 Reducing Stigma in People Who Inject Drugs with HIV Using a Rapid Start Antiretroviral Therapy Intervention Frederick L Altice, M.D. Fogarty International Center/National Institute on Drug Abuse 07/15/2023 06/30/2026 R01 Further Detail
94 Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence Lynn E. Fiellin, M.D. The Robert Wood Johnson Foundation 07/01/2006 06/30/2009
95 Reducing HIV Risk in Methadone-Maintained Patients S. Kelly Avants, Ph.D. National Institute on Drug Abuse 01/20/1999 12/31/2003 R01 Further Detail
96 Reducing HIV Risk Behaviors Among Homeless Women Connie Nickou, Psy. D CIRA 09/01/2001 08/31/2002 CIRA Pilot
97 Reducing High Risk Behavior in HIV Positive Drug Abusers S. Kelly Avants, Ph.D. National Institute on Drug Abuse 09/30/1996 08/31/2002 R01 Further Detail
98 Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention Lynn E. Fiellin, M.D. National Institute on Alcohol Abuse and Alcoholism 09/30/2009 08/31/2014 R01 Further Detail
99 Rectal and Vaginal Dendritic Cells in SIV Infection Akiko Iwasaki, Ph.D. amfAR 06/01/2001 05/31/2002
100 Rapid Assessment and Response to Substance Use and Risk of HIV and Other Blood-Borne Infections Among Displaced Populations in Beirut, Lebanon Kaveh Khoshnood, Ph.D., M.P.H. National Institute of Mental Health CIRA Pilot Project
101 Randomized Controlled Trial to Enhance Dual Protection among PLHIV in India Trace Kershaw, Ph.D. National Institute of Child Health and Human Development 09/10/2009 08/31/2013 R01 Further Detail
102 Raising the Voice of the African Decade of Disabled Persons Nora Ellen Groce, Ph.D. Rehabilitation International 01/01/2006 12/31/2006
103 Racial/ethnic Differences in Daily Dynamics of PTSD, Sexual-Risk & Substance Use Tami P. Sullivan, Ph.D. National Institute on Drug Abuse 07/15/2011 05/31/2016 R01 Further Detail
104 R3EDI - Rigorous, Rapid, & Relevant Evidence aDaptation & Implementation to EHE Trace Kershaw, Ph.D. National Institute of Mental Health 09/30/2021 02/28/2023 P30 Further Detail
105 R3EDI - Rigorous, Rapid, & Relevant Evidence aDaptation & Implementation to EHE Donna Spiegelman, Sc.D. National Institute of Mental Health 09/30/2021 02/28/2023 P30 Further Detail
106 Public Health Impact and Cost-Effectiveness of HIV Interventions Edward H. Kaplan, Ph.D. National Institute on Drug Abuse 06/15/1996 08/31/2002 R01 Further Detail
107 Provision of Tuberculosis and Antiretroviral Therapy in Rural KwaZulu Natal Gerald H. Friedland, M.D. Irene Diamond Fund 10/01/2002 12/31/2008
108 Provision of HIV Care and Antiretroviral Therapy Through a Strengthened Community-Based Tuberculosis Directly Observed Therapy Program in Rural South Africa: The Sizon’qoba ("We Shall Overcome") Project Gerald H. Friedland, M.D. Doris Duke Foundation 11/05/2004 11/14/2008
109 Provider-initiated HIV Prevention and Sexual Health Promotion with Couples Natalie Leblanc, Ph.D., M.P.H., R.N., B.S.N. Research Education Institute for Diverse Scholars (REIDS) 02/01/2019 05/31/2020 REIDS Pilot Project
110 Promoting Retention in Opioid Treatment among Women Experiencing Intimate Partner Violence: A Novel Stepped Care Model Targeting PTSD Tami P. Sullivan, Ph.D. National Institute on Drug Abuse 09/30/2023 08/31/2025 R61 Further Detail
111 Promoting Retention in Opioid Treatment among Women Experiencing Intimate Partner Violence: A Novel Stepped Care Model Targeting PTSD E. Jennifer Edelman, MD, MHS, BS National Institute on Drug Abuse 09/30/2023 08/31/2025 R61 Further Detail
112 Promoting Resilience in Young Children of HIV-infected Mothers in South Africa National Institute of Mental Health 09/30/2005 12/31/2011 R01 Further Detail
113 Promoting Mental and Sexual Health among Young Pregnant Women in Liberia Tamora Callands, Ph.D. Fogarty International Center 09/20/2013 12/31/2018 K01 Further Detail
114 Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management with PrEP Navigation E. Jennifer Edelman, MD, MHS, BS National Institute on Drug Abuse 07/01/2020 05/31/2025 R01 Further Detail
115 Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications, and CBT4CBT: A randomized clinical trial in a diverse patient population E. Jennifer Edelman, MD, MHS, BS National Institute on Alcohol Abuse & Alcoholism R01 09/20/2021 05/31/2026 R01 Further Detail
116 Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications, and CBT4CBT: A randomized clinical trial in a diverse patient population Brian D. Kiluk, Ph.D. National Institute on Alcohol Abuse & Alcoholism R01 09/20/2021 05/31/2026 R01 Further Detail
117 Project TRUST: Directly Observed Anti-Retroviral Therapy Among Active Drug Users Frederick L Altice, M.D. National Institute on Drug Abuse 09/29/2000 09/28/2005 R01 Further Detail
118 Project TRANSITIONS: Enhancing Linkages to HIV Primary Care in Jail Settings Frederick L Altice, M.D. Health Resources and Services Administration 09/01/2007 08/31/2013 Further Detail
119 Project S.T.E.P. (Sex Talk to Empower Parents): Parents as HIV/STI Prevention Agents for Gay, Bisexual, and Queer Adolescents Through Comprehensive Parent-Child Sex Communication Dalmacio Dennis Flores, PhD, ACRN National Institute of Mental Health 08/02/2018 08/01/2019 REIDS Pilot Project
120 Project Parivartan: Structural Interventions and HIV Prevention among Sex Workers, their Clients, and Injection Drug Users in India Kim M. Blankenship, Ph.D. Bill and Melinda Gates Foundation 05/01/2004 12/31/2007
121 Project Parivartan: Structural Interventions and HIV Prevention among Sex Workers, their Clients, and Injection Drug Users in India Kim M. Blankenship, Ph.D. Bill and Melinda Gates Foundation 05/01/2004 12/31/2007
122 Project Parivartan: Structural Interventions and HIV Prevention among Sex Workers and their Clients in India (supplement) Kim M. Blankenship, Ph.D. Bill and Melinda Gates Foundation 07/01/2007 12/31/2010
123 Project CONNECT Centers for Disease Control 09/01/2014 08/31/2019 U01 Further Detail
124 Project CONNECT Merceditas Villanueva, M.D. Centers for Disease Control 09/01/2014 08/31/2019 U01 Further Detail
125 Project CIRCLE: CIRA International HIV Research Capacity and Collaboration: An Exploratory Study Kaveh Khoshnood, Ph.D., M.P.H. National Institute of Mental Health 06/03/2019 06/02/2020 CIRA Pilot Project
126 Project CIRCLE: CIRA International HIV Research Capacity and Collaboration: An Exploratory Study Dini Harsono, M.Sc. National Institute of Mental Health 06/03/2019 06/02/2020 CIRA Pilot Project
127 Project CHOICES: Targeted Capacity Expansion Program for Substance Abuse Treatment and HIV/AIDS Frederick L Altice, M.D. Center for Substance Abuse Treatment 09/30/2008 09/29/2013 Further Detail
128 Project C.O.A.C.H.: Counseling Others About Contacts and Exposures with HIV E. Jennifer Edelman, MD, MHS, BS Robert Wood Johnson Foundation 07/01/2011 06/30/2012
129 Project BEST: Buprenorphine Treatment Expansion in HIV Clinical Settings Frederick L Altice, M.D. Center for Substance Abuse Treatment 12/01/2003 11/20/2008
130 Prisons, Drug Injection and the HIV Risk Environment Jaimie Meyer, M.D., M.S., F.A.C.P. National Institute on Drug Abuse 08/01/2017 07/31/2019 R21 Further Detail
131 Prison Interventions and HIV Prevention Collaboration Frederick L Altice, M.D. National Institute on Drug Abuse 09/01/2010 07/31/2020 R01 Further Detail
132 Prevention with Newly HIV+ Men: A Pilot Intervention-Supplement to P30MH66294-05 Paul D. Cleary, Ph.D. Office of AIDS Research 09/15/2006 06/30/2008 P30
133 Preventing HIV/AIDS by Building Capacity to Reduce Stigma Among Providers for Pregnant Women in Rural Haiti Jasmine Abrams, Ph.D. Fogarty International Center 07/01/2018 04/30/2020 R21 Further Detail
134 Preventing & Treating HIV Comorbidities in India: Multi-tiered Strategy for Women Nancy Reynolds, R.N, Ph.D., F.A.A.N. National Institute of Allergy and Infectious Disease 09/25/2013 07/31/2016 R21 Further Detail
135 Preparing for Pre-Exposure Prophylaxis Implementation in Central-Eastern European Countries with Low Access to Biomedical Prevention John Pachankis, Ph.D. Fogarty International Center 09/09/2020 06/30/2022 R21 Further Detail
136 PrEP for HIV Prevention in MSM: Mixed-Methods Study of Behavior & Message Framing National Institute of Mental Health 06/01/2011 05/31/2017 K01 Further Detail
137 Pre-exposure prophylaxis, medical mistrust, stigma, and medication beliefs among a diverse sample of young adult men Jessica Jaiswal, Ph.D., M.P.H. National Institute of Mental Health 05/31/2018 05/30/2019 REIDS Pilot Project
138 Pre-exposure Prophylaxis Implementation for HIV Prevention among Substance-using Men who Have Sex with Men Trace Kershaw, Ph.D. National Institute of Mental Health 11/13/2017 11/12/2018 CIRA Pilot Project
139 Pre-exposure Prophylaxis Implementation for HIV Prevention among Substance-using Men who Have Sex with Men Philip A. Chan, M.D. National Institute of Mental Health 11/13/2017 11/12/2018 CIRA Pilot Project
140 Pre-exposure Prophylaxis Implementation for HIV Prevention among Substance-using Men who Have Sex with Men Jacob van den Berg, Ph.D, M.S. National Institute of Mental Health 11/13/2017 11/12/2018 CIRA Pilot Project
141 Pre-exposure Prophylaxis Implementation for HIV Prevention among Substance-using Men who Have Sex with Men E. Jennifer Edelman, MD, MHS, BS National Institute of Mental Health 11/13/2017 11/12/2018 CIRA Pilot Project
142 Potential for HIV Transmission in Relationships of Drug-using Women in Russia Linda Niccolai, Ph.D. National Institute on Drug Abuse 09/01/2008 08/31/2011 R21 Further Detail
143 Population Size, Characteristics & HIV Risks among Transgender People in Hartford Margaret R. Weeks, Ph.D. CIRA 01/06/2010 01/05/2011 CRPP
144 Population Size, Characteristics & HIV Risks among Transgender People in Hartford CIRA 01/06/2010 01/05/2011 CRPP
145 Population Size, Characteristics & HIV Risks among Transgender People in Hartford Jerimarie Liesegang, Ph.D. CIRA 01/06/2010 01/05/2011 CRPP
146 Pilot Intervention Research: Brief Care-based HIV Prevention for Newly Diagnosed Men Robert Heimer, Ph.D. Gilead Foundation 09/01/2006 02/29/2008
147 Physician Delivered Intervention with HIV+ Individuals National Institute of Mental Health 07/15/1999 06/30/2005
148 Phylodynamic Analysis of HIV Transmission Clusters in Kazakhstan for Targeted Interventions Sten H. Vermund, M.D., Ph.D. National Institute on Drug Abuse 07/15/2020 06/30/2022 R03 Further Detail
149 Phenotype and Genotype of HIV-1 Strains from Children Warren A. Andiman, M.D. National Institute of Allergy and Infectious Disease 08/01/1996 07/31/2002 R01 Further Detail
150 Pediatric HIV Disclosure Benefits Study (PhD-BS) - Sankofa 2 Elijah Paintsil, M.D. Eunice Kennedy Shriver National Institute of Child Health and Human Development 08/15/2020 06/30/2025 R01 Further Detail
151 Participatory System Dynamics Modeling to Simulate HIV Test-and Treat Improvements Margaret R. Weeks, Ph.D. National Institute of Mental Health 07/15/2016 06/30/2018 R21 Further Detail
152 Participant Perspectives on Drug Use/HIV Research Ethics National Institute on Drug Abuse 09/20/2005 07/31/2008 R01 Further Detail
153 Parenteral HCV Transmission: Assessing Risks and Prevention Strategies in Vitro Robert Heimer, Ph.D. National Institute on Drug Abuse 09/01/2011 06/30/2016 R01 Further Detail
154 Overweight/Obesity and Weight Gain among HIV-Positive Prisoners in Rhode Island: Prevalence and Intervention Feasibility Amy Smoyer, Ph.D. NIMH through CIRA's Pilot Project Program 10/03/2014 10/02/2015 Pilot Project
155 Optimizing PrEP's Potential in Non-Clinical Settings: Development and Evaluation of a PrEP Shared Decision Making Tool for Women Seeking Domestic Violence Services Jaimie Meyer, M.D., M.S., F.A.C.P. National Institute of Mental Health 11/15/2019 11/14/2020 CIRA Pilot Project
156 Optimizing PrEP's Potential in Non-Clinical Settings: Development and Evaluation of a PrEP Shared Decision Making Tool for Women Seeking Domestic Violence Services Tiara C. Willie, Ph.D. National Institute of Mental Health 11/15/2019 11/14/2020 CIRA Pilot Project
157 Optimizing Auricular Acupuncture for HIV+ Drug Abusers Arthur Margolin, Ph.D. National Institute on Drug Abuse 04/10/1999 03/31/2003
158 Optimizing ACT Use for African Children in the Setting of HIV and Malnutrition Fran Aweeka Eunice Kennedy Shriver National Institute of Child Health and Human Development 12/23/2010 08/31/2021 RO1 Further Detail
159 Opioids & HIV Medications: Interactions in Drug Abusers Gerald H. Friedland, M.D. National Institute on Drug Abuse 04/20/1999 07/31/2011 R01
160 Online Respondent-Driven Sampling & Data Collection Edward White, Ph.D. National Institute of Mental Health 01/01/2011 12/31/2013 R21 Further Detail
161 Off-Site Sexually Transmitted Infection Testing for Connecticut Men Who Have Sex with Men CIRA 08/13/2010 08/12/2011 CRPP
162 Off-Site Sexually Transmitted Infection Testing for Connecticut Men Who Have Sex with Men Christopher Cole, B.S. CIRA 08/13/2010 08/12/2011 CRPP
163 Nursing Intervention to Improve Antiviral Adherence Ann B. Williams, R.N.C., Ed.D. National Institute of Nursing Research 09/30/1998 08/31/2002
164 Novel, Adaptive Approaches to Predicting and Responding to Outbreaks of Overdose, HIV and HCV among People Who Use Drugs Gregg Gonsalves, Ph.D. National Institute on Drug Abuse 07/01/2019 05/31/2024 DP2 Further Detail
165 Non-Medical Use of Prescription Opioids Among HIV-Infected Individuals: Trajectories and Impact On Health Outcomes E. Jennifer Edelman, MD, MHS, BS National Institute on Drug Abuse 08/01/2016 04/30/2019 R01 Further Detail
166 NIMH Collaborative HIV/STD Prevention Trial (Russia) Jeffrey A. Kelly, Ph.D. National Institute of Mental Health 09/30/1999 08/31/2009 U10 Further Detail
167 New Methods for the Design and Evaluation of Large HIV Prevention nterventions Donna Spiegelman, Sc.D. National Institute of Allergy and Infectious Diseases 06/01/2014 06/30/2018 R01 Further Detail
168 Network-Based Epidemiology for Hidden and Hard-To-Reach Populations Forrest W. Crawford, Ph.D. Office of the Director, National Institutes of Health 09/14/2016 08/31/2021 DP2 Further Detail
169 Neighborhood Impact on HIV, Drug Abuse, and Criminal Justice Outcome Frederick L Altice, M.D. CIRA 03/01/2013 06/30/2013 Pilot Project
170 Neighborhood Impact on HIV, Drug Abuse, and Criminal Justice Outcome Debarchana (Debs) Ghosh, Ph.D. CIRA 03/01/2013 06/30/2013 Pilot Project
171 National AIDS Prevention Research Centers Proposed Multi-Level Intervention Planning Workshops Paul D. Cleary, Ph.D. Office of AIDS Research 01/01/2010 06/30/2012
172 Naltrexone for Opiod Dependent Released HIV+ Criminal Justice Populations Sandra Ann Springer, M.D. National Institute on Drug Abuse 09/30/2010 08/31/2016 R01 Further Detail
173 Multilevel determinants of HIV and STI testing among transmasculine individuals of color Madina Agénor, Sc.D., M.P.H. National Institute of Mental Health 08/03/2018 08/02/2019 REIDS Pilot Project
174 Multidrug-resistant Tuberculosis and HIV: Composition of Strains and Biomarkers of Treatment Response Patrick Cudahy, M.D. Fogarty International Center 09/16/2019 06/30/2024 K01 Further Detail
175 Multidisciplinary HIV and TB Implementation Sciences Training in China Kaveh Khoshnood, Ph.D., M.P.H. Fogarty International Center 07/01/2009 03/31/2015 U2R Further Detail
176 Multi-State Study of Factors Affecting the Implementation and Utilization of Partner Services for HIV-Positive MSM (Project PS) Paul D. Cleary, Ph.D. National Institute of Mental Health 05/10/2018 02/29/2020 CIRA Pilot Project
177 Multi-State Study of Factors Affecting the Implementation and Utilization of Partner Services for HIV-Positive MSM (Project PS) Margaret R. Weeks, Ph.D. National Institute of Mental Health 05/10/2018 02/29/2020 CIRA Pilot Project
178 Multi-State Study of Factors Affecting the Implementation and Utilization of Partner Services for HIV-Positive MSM (Project PS) Jacob van den Berg, Ph.D, M.S. National Institute of Mental Health 05/10/2018 02/29/2020 CIRA Pilot Project
179 Multi-Level Intervention Addressing Intersectional Stigma to Improve HIV Testing in MSM LaRon E. Nelson, PhD, RN, FNP, FNAP, FAAN National Institute of Nursing Research 09/05/2019 06/30/2023 R01 Further Detail
180 Monitoring and Evaluation of an ARV Pilot Program in Tamil Nadu, India Michael H. Merson, M.D. Children's Investment Fund Foundation (India) 08/01/2004 10/31/2006
181 Models of health care delivery for people living with HIV: Influences on treatment adherence and HIV risk behaviors and the role of psychosocial factors Fogarty International Center 09/01/2012 06/30/2013 Mentored Trainee Research Project
182 Models of health care delivery for people living with HIV: Influences on treatment adherence and HIV risk behaviors and the role of psychosocial factors Fogarty International Center 09/01/2012 06/30/2013 Mentored Trainee Research Project
183 Models of health care delivery for people living with HIV: Influences on treatment adherence and HIV risk behaviors and the role of psychosocial factors Fogarty International Center 09/01/2012 06/30/2013 Mentored Trainee Research Project
184 Models of health care delivery for people living with HIV: Influences on treatment adherence and HIV risk behaviors and the role of psychosocial factors Fogarty International Center 09/01/2012 06/30/2013 Mentored Trainee Research Project
185 Modeling the impact and cost-effectiveness of opioid agonist treatments to reduce the negative consequences of incarceration on HIV and TB transmission in Eastern Europe and Central Asia Frederick L Altice, M.D. National Institute on Drug Abuse 09/30/2020 08/31/2022 R21 Further Detail
186 Modeling HIV Subjects' Electronic Monitoring Data George Knafl, Ph.D. National Institute of Allergy and Infectious Disease 02/01/2004 10/31/2008 R01
187 Modeling HIV & Substance Abuse: Correcting Sampling Bias and Cost Effectiveness Alexei Zelenev, Ph.D. National Institute on Drug Abuse 06/15/2014 05/31/2019 K01 Further Detail
188 Modeling HCV/HIV Transmission and Treatment as Prevention in U.S. Networks of People Who Inject Drugs Frederick L Altice, M.D. National Institute on Drug Abuse 04/01/2016 03/31/2018 R21 Further Detail
189 Mobile Health for Implementation of Home-Based TB Contact Investigation in Uganda Luke Davis, M.D. National Institute of Allergy and Infectious Diseases 06/17/2013 05/31/2018 R01 Further Detail
190 Mobile Health and Oral Testing to Optimize Tuberculosis Contact Tracing in Colombia Luke Davis, M.D. National Institute of Allergy and Infectious Diseases 02/02/2023 01/31/2025 R21 Further Detail
191 Minority Youth Action Research Training Institute Jean J. Schensul, Ph.D. National Institute of Mental Health 09/30/1998 06/30/2004
192 MIEL: Meditation and Massage in End of Life David L. Katz, M.D.,M.P.H National Institute of Nursing Research 09/30/2001 04/30/2004
193 MIDAS Center for Communicable Disease Dynamics National Institute of General Medical Sciences 09/15/2009 08/31/2017 U54 Further Detail
194 Microbicide/Female Condom Acceptability for Sex Workers in China Margaret R. Weeks, Ph.D. National Institute of Mental Health/Fogarty International Center 05/15/2003 04/30/2007 RO3 Further Detail
195 Microbicide Acceptance--Prevent HIV in High-Risk Women Margaret R. Weeks, Ph.D. National Institute of Mental Health 09/30/2000 08/31/2004 R01 Further Detail
196 mHEALTH: Medical Home Engagement and Aligning Lifestyles and Transition from Homelessness Frederick L Altice, M.D. Health Resources and Services Administration 09/01/2012 08/31/2017 Special Project of National Significance (SPNS) grant Further Detail
197 Mental Illness Stigma as a Risk Factor for Substance Use among Adults with Depression Katie Wang, Ph.D. National Institute on Drug Abuse 02/01/2019 01/31/2024 K01 Further Detail
198 Medication Assisted Therapy as a Conduit to Care for HIV+ CJS Populations Transit Sandra Ann Springer, M.D. National Institute on Drug Abuse 07/01/2011 06/30/2016 K02 Further Detail
199 MATCH (Minority Addiction Treatment Co-Location with HIV Services) Frederick L Altice, M.D. Substance Abuse and Mental Health Services Administration (SAMHSA)
200 Markers of Alcohol Toxicity in HIV-Infected Veterans National Institute on Alcohol Abuse and Alcoholism 09/30/2005 08/31/2008
201 Managing Health during Humanitarian Crises: Resilience, Establishing Health Priorities, and impact on Health Care Workers Yulia Rozanova, Ph.D. The Whitney and Betty MacMillan Center for international and Area Studies at Yale Yale MacMillan Center Kempf Award Further Detail
202 Managing Health during Humanitarian Crises: Resilience, Establishing Health Priorities, and impact on Health Care Workers Sheela V. Shenoi, M.D.,M.P.H The Whitney and Betty MacMillan Center for international and Area Studies at Yale Yale MacMillan Center Kempf Award Further Detail
203 Malaysian Implementation Science Training (MIST) Program in HIV Frederick L Altice, M.D. Fogarty International Center 04/22/2020 12/31/2024 D43 Further Detail
204 Malaysian Implementation Science Training (MIST) Program in HIV Frederick L Altice, M.D. Fogarty International Center 04/22/2020 12/31/2024 D43 Further Detail
205 Making Better Decisions: Policy Modeling for AIDS and Drug Abuse National Institute on Drug Abuse 09/25/2002 01/31/2018 R01 Further Detail
206 Longitudinal Study of the RAP Peer Intervention for HIV Margaret R. Weeks, Ph.D. National Institute on Drug Abuse 08/01/2000 04/30/2008 R01 Further Detail
207 Longitudinal Exploration of Pathways to HIV/STI Risk Reduction among Homeless Young Adults through a Youth-Centric Rapid Re-Housing Program Heather Mosher, Ph.D. National Institute of Mental Health 09/01/2020 08/31/2022 R21 Further Detail
208 Long-Acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-Involved Adults Sandra Ann Springer, M.D. National Institute on Drug Abuse 08/01/2019 04/30/2024 U01 Further Detail
209 Liver cancer risk and prevention among persons living with HIV/AIDS Lesley Park, Ph.D., M.P.H. National Cancer Institute 09/01/2013 06/29/2015 F31 Further Detail
210 Literature and Good Practice Review: Strategic Approaches to Care for Orphaned and Vulnerable Children Shelley Geballe, J.D. CIRA 08/11/2002 11/07/2003
211 LEveraging A viRtual eNvironment (LEARN) to Enhance Prevention of HIV-related Comorbidities in at-risk Minority MSM S Raquel Ramos, FNP-BC, MBA, MSN, PhD National Heart Lung and Blood Institute 09/01/2019 07/31/2024 K01 Further Detail
212 Latinos Living with HIV/AIDS -- Access to Subacute Care Jean M. Breny, Ph.D., M.P.H. CIRA 04/05/2007 04/04/2008 CRPP
213 Latinos Living with HIV/AIDS -- Access to Subacute Care Martha Dale CIRA 04/05/2007 04/04/2008 CRPP
214 Knowledge, Attitudes and Practices of Key Groups about the Undetectable=Untransmissible Message (KAP on U=U) Trace Kershaw, Ph.D. National Institute of Mental Health 02/15/2022 02/14/2023 P30 EHE Supplement Grant
215 Knowledge, Attitudes and Practices of Key Groups about the Undetectable=Untransmissible Message (KAP on U=U) Carmen Zorrilla, M.D. National Institute of Mental Health 02/15/2022 02/14/2023 P30 EHE Supplement Grant
216 Intervention to Reduce HIV/STD Risk in Teen Pregnancy Jeannette R. Ickovics, Ph.D. National Institute of Mental Health 04/24/2001 03/31/2007 R01 Further Detail
217 Intervention to Reduce Acute Stress and HIV Risk in Newly HIV Diagnosed Men Trace Kershaw, Ph.D. National Institute of Mental Health 06/21/2010 05/31/2014 R34 Further Detail
218 Intervention To Promote PrEP Awareness and Equitable Prescription Among Providerss Sarah K. Calabrese, Ph.D. NIMH 05/01/2014 04/30/2018 K01 Further Detail
219 Intervention to Overcome Mental Health Disparities in Criminally-Justice Involved Transgender Women Jaclyn White Hughto, M.P.H. National Institute on Minority Health and Health Disparities 09/01/2016 08/31/2018 F31 Further Detail
220 Intervention to encourage HIV Testing and Counseling among Adolescents Lynn E. Fiellin, M.D. NICHD 05/01/2016 04/30/2017 R41 Further Detail
221 Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia Frederick L Altice, M.D. National Institute on Drug Abuse 09/30/2008 06/30/2015 R01 Further Detail
222 Intervention Development for Social Stress, Mental Health, and HIV Risk among MSM John Pachankis, Ph.D. National Institute of Mental Health 07/01/2012 04/30/2016 R34 Further Detail
223 Intersectional Stigma, Mental Health, and HIV Risk among US Gay and Bisexual Men of Color Skyler Jackson, Ph.D. National Institute of Mental Health 08/05/2020 07/31/2024 K01 Further Detail
224 Interrupting HIV stigma in the household using home HIV testing offers in South Africa Luke Davis, M.D. National Institute of Mental Health 09/16/2019 09/15/2020 CIRA Pilot Project
225 Interrupting HIV stigma in the household using home HIV testing offers in South Africa Mari Armstrong-Hough, M.P.H., Ph.D. National Institute of Mental Health 09/16/2019 09/15/2020 CIRA Pilot Project
226 Interrupting HIV and TB Stigma in the Household During TB Contact Investigation in Uganda Luke Davis, M.D. Fogarty International Center 04/15/2019 02/28/2021 R21 Further Detail
227 Internet-Based HIV Prevention Technology Transfer with World NGOs Jeffrey A. Kelly, Ph.D. National Institute of Mental Health 09/30/2001 08/31/2006
228 International Research Training on TB and Other Pulmonary Complications of HIV Luke Davis, M.D. Fogarty International Center 08/01/2013 01/31/2018 D43 Further Detail
229 International Feasibility Study of Pharmacy-Based HIV Prevention: St. Petersburg Robert Heimer, Ph.D. National Institute on Drug Abuse 09/15/2009 08/31/2011 R21 Further Detail
230 International Clinical Research Fellowship Gerald H. Friedland, M.D. Doris Duke Charitable Foundation 07/01/2012 06/30/2017 Further Detail
231 Interdisciplinary HIV Prevention Training Program Trace Kershaw, Ph.D. National Institute of Mental Health 07/01/1999 06/30/2019 T32 Further Detail
232 Interactive Effects of Alcohol and Polydrug Use on Sexual Risk Taking among Youth Cross Nationally Jean J. Schensul, Ph.D. CIRA 05/10/2002 05/09/2003
233 Integration of TB and HIV in Community Settings Gerald H. Friedland, M.D. Health Systems Trust 10/01/2015 09/30/2016
234 Integrating Sex and Drug Related HIV Risk and Transmission (Diversity Supplement) Robert Heimer, Ph.D. National Institute on Drug Abuse 07/01/2005 06/30/2008 U01
235 Integrating Prenatal Care to Reduce HIV/STDs Among Teens: A Translational Study Jeannette R. Ickovics, Ph.D. National Institute of Mental Health 08/18/2006 01/31/2013 R01 Further Detail
236 Integrating HIV Prevention into Clinical Care for PLWHA in South Africa National Institute of Mental Health 01/01/2007 12/31/2012 R01
237 Integrating HIV and Depression Self Care to Improve Adherence in Perinatal Women Nancy Reynolds, R.N, Ph.D., F.A.A.N. National Institute of Mental Health 08/15/2014 07/31/2018 R21 Further Detail
238 Integrating Genomic and Spatial Approaches for Targeted Control of HIV-Associated Tuberculosis Epidemics Ted Cohen, M.D.,M.P.H National Institute of Allergy and Infectious Diseases 08/01/2020 07/31/2024 R01 Further Detail
239 Integrating Buprenorphine into HIV Clinical Care Settings Frederick L Altice, M.D. Health Resources and Services Administration 09/01/2006 08/31/2009
240 Integrating Addiction Treatment and HIV Services Into Primary Care Clinics in Ukraine Frederick L Altice, M.D. National Institute on Drug Abuse 09/15/2016 06/30/2021 R01 Further Detail
241 Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings Frederick L Altice, M.D. National Institute on Drug Abuse 08/01/2021 05/31/2026 R01 Further Detail
242 Integrated Stepped Care for Unhealthy Alcohol Use in HIV David A. Fiellin, M.D. National Institute on Alcohol Abuse and Alcoholism 09/15/2011 08/31/2016 U01 Further Detail
243 Integrated rapid access to HIV prevention program for people who inject drugs (iRaPID) Roman Shrestha, Ph.D., M.P.H. National Institute on Drug Abuse 08/01/2020 07/31/2022 R21 Further Detail
244 Integrated eHealth for HIV and Substance Use Disorders in Justice-involved Women Jaimie Meyer, M.D., M.S., F.A.C.P. National Institute on Drug Abuse 09/15/2022 06/30/2027 R01 Further Detail
245 Innovations in Implementing Decentralized HIV Services in Peru Frederick L Altice, M.D. National Institute of Allergy and Infectious Diseases 07/06/2023 06/30/2028 R01 Further Detail
246 Injection Drug Use within the Family Context: Damage Limitation, Qualification, and Acceptance Lauretta Grau, Ph.D. CIRA 02/01/2012 01/31/2013 Pilot Project
247 Influences on HIV Prevalence and Service Access among IDUs in Russia and Estonia Robert Heimer, Ph.D. National Institute on Drug Abuse 09/01/2010 07/31/2016 R01 Further Detail
248 Influences on HIV Prevalence and Service Access among IDUs in Russia and Estonia National Institute on Drug Abuse 09/01/2010 07/31/2016 R01 Further Detail
249 Increasing Provider Competence for Treating Stress-related Mental Health Conditions in Low Resource Settings Corina Lelutiu-Weinberger, Ph.D. National Institute of Mental Health 08/01/2017 07/31/2019 R21 Further Detail
250 Increasing Provider Competence for Treating Stress-related Mental Health Conditions in Low Resource Settings John Pachankis, Ph.D. National Institute of Mental Health 08/01/2017 07/31/2019 R21 Further Detail
251 Increasing Drug Users' Adherence to HIV Therapeutics Robert S. Broadhead, Ph.D. National Institute on Drug Abuse 12/25/1999 11/30/2004
252 Inclusion of HIV/AIDS Educational Messages in Traditional 'Rites of Passage' Nora Ellen Groce, Ph.D. CIRA 07/01/2003 06/30/2004
253 Improving the Hepatitis C Cascade of Care Among HIV/HCV Coinfected Persons of Color in Connecticut Merceditas Villanueva, M.D. Health Resources and Services Administration (HRSA)
254 Improving Sexual Communication Between Parents and Their Deaf Teens: A Critical Gap in Needs Nora Ellen Groce, Ph.D. CIRA 09/28/2004 09/27/2005 CRPP
255 Improving Sexual Communication Between Parents and Their Deaf Teens: A Critical Gap in Needs CIRA 09/28/2004 09/27/2005 CRPP
256 Improving Isoniazid Prevention Therapy (IPT) Penetration through Intensification of Case Finding at the Community Level in Rural South Africa Anthony Moll Center for Global Health 08/01/2012 07/31/2017 U01 Further Detail
257 Improving HIV testing and PrEP for transgender women through mHealth Jeffrey A. Wickersham, Ph.D. National Institute of Allergy and Infectious Diseases (NIAID) 04/28/2021 03/31/2023 R21 Further Detail
258 Improving HIV testing and PrEP for transgender women through mHealth Roman Shrestha, Ph.D., M.P.H. National Institute of Allergy and Infectious Diseases (NIAID) 04/28/2021 03/31/2023 R21 Further Detail
259 Improving HIV and Substance Use Disorder Treatment Research by Integrating Randomized and Nonrandomized Studies: An Evaluation of Methadone for HIV-infected Opioid-dependent Malaysian Prisoners Alexander Bazazi, M.D., Ph.D. National Institute on Drug Abuse 03/16/2015 03/15/2018 F30 Further Detail
260 Improving Health Outcomes for Released HIV+ Prisoners Frederick L Altice, M.D. National Institute on Drug Abuse 04/20/2006 03/31/2010 R21 Further Detail
261 Improving Antiretroviral Adherence and Persistence Using MHealth Tools in HIV-Infected Cocaine Users Frederick L Altice, M.D. National Institute on Drug Abuse 08/01/2016 07/31/2018 R21 Further Detail
262 Implementing PrEP in a Family Planning Setting Sarah K. Calabrese, Ph.D. National Institute of Mental Health 06/14/2016 06/13/2017 CIRA Pilot Project
263 Implementing Point of Care CD4 Analysis to Decentralize HIV Care in Rural Africa Gerald H. Friedland, M.D. National Institute of Allergy and Infectious Diseases 08/01/2012 07/31/2015 R21
264 Implementing Point of Care CD4 Analysis to Decentralize HIV Care in Rural Africa Sheela V. Shenoi, M.D.,M.P.H National Institute of Allergy and Infectious Diseases 08/01/2012 07/31/2015 R21
265 Implementation of Seek, Test, Treat & Retain Strategies among People Who Inject Drugs in Malaysia Marek Chawarski, Ph.D. National Institute on Drug Abuse 09/01/2018 07/31/2023 R01 Further Detail
266 Implementation of HIV Pre-Exposure Prophylaxis for Men who have Sex with Men with and without Substance Use in Providence and New Haven Philip A. Chan, M.D. National Institute of Mental Health 04/24/2015 04/30/2016
267 Implementation of HIV Pre-Exposure Prophylaxis for Men who have Sex with Men with and without Substance Use in Providence and New Haven E. Jennifer Edelman, MD, MHS, BS National Institute of Mental Health 04/24/2015 04/30/2016
268 Implementation of HIV Pre-Exposure Prophylaxis for Men who have Sex with Men with and without Substance Use in Providence and New Haven National Institute of Mental Health 04/24/2015 04/30/2016
269 Implementation of HIV Pre-Exposure Prophylaxis for Men who have Sex with Men with and without Substance Use in Providence and New Haven Onyema Ogbuagu, M.D. National Institute of Mental Health 04/24/2015 04/30/2016
270 Impediments to Syringe Exchange Use by Minority Women Robert Heimer, Ph.D. National Institute of Mental Health 08/01/1999 07/31/2000
271 IMPART: A Provider-Assisted HIV Partner Notification & Testing Intervention for Prisoners in Indonesia Gabriel John Culbert, Ph.D. National Institute of Mental Health 09/14/2018 06/30/2021 R34 Further Detail
272 Impacts of Individual and Social Behavior on Influenza Dynamics and Control National Institute of General Medical Sciences 06/01/2009 04/30/2014 U01 Further Detail
273 Immunologic Profiles of Distinct Cognitive Trajectories in Adults with Perinatal HIV Payal Patel, M.D. National Institute of Mental Health 07/11/2019 06/30/2024 K23 Further Detail
274 Illicit Opiate Use in Maine Robert Heimer, Ph.D. Purdue-Pharma LLP 06/01/2002 05/30/2003
275 IDU Peer Recruitment Dynamics and Network Structure in Respondent Driven Sampling JiangHong Li, M.D., M.Sc. National Institute on Drug Abuse 03/15/2011 02/28/2014 R01 Further Detail
276 Identifying Modifiable Risk and Protective Processes at the Day-Level that Predict HIV Care Outcomes Among Women Exposed to Partner Violence Tami P. Sullivan, Ph.D. National Institute of Mental Health 01/01/2020 11/30/2024 R01 Further Detail
277 Identifying Modifiable Risk and Protective Processes at the Day-Level that Predict HIV Care Outcomes Among Women Exposed to Partner Violence Jaimie Meyer, M.D., M.S., F.A.C.P. National Institute of Mental Health 01/01/2020 11/30/2024 R01 Further Detail
278 Identifying HIV-Bridge-Population in STI Clinics, Russia National Institute on Drug Abuse 09/25/2005 07/31/2008 R03 Further Detail
279 Identifying Culturally Appropriate Peer-based Interventions for Monolingual Spanish Speaking and Bilingual Hispanic Women with HIV, Substance Abuse, and Intimate Partner Violence: Preliminary Research Cristina Cruza-Guet, Ph.D. CIRA 03/26/2012 03/25/2013 Pilot Project
280 Identifying Adolescents at Risk for Transitioning into Injection Drug Use in Russian Cities: Preliminary Research Nathan Hansen, Ph.D. CIRA 09/10/2010 09/09/2011 CIRA Pilot
281 Human-Centered Design and Communities of Practice to Improve Delivery of Home-Based TB Contact Investigation in Uganda Luke Davis, M.D. National Institute of Allergy and Infectious Diseases 06/17/2013 12/31/2023 R01 Further Detail
282 HIV/STI Risk Behaviors, Mental Health, and Immigration: The Experiences of Immigrants Pre- and Post-Migration Sarah Abboud, Ph.D. Research Education Institute for Diverse Scholars (REIDS) 05/02/2018 05/31/2020 REIDS Pilot Project
283 HIV/STD Risk among Young Expectant Fathers: Relationship Attachment and Transition (2nd Diversity Supplement) Trace Kershaw, Ph.D. National Institute of Mental Health 06/01/2009 09/30/2012
284 HIV/STD Risk among Young Expectant Fathers: Relationship Attachment (Diversity supplement) Trace Kershaw, Ph.D. National Institute of Mental Health 08/14/2008 07/31/2009
285 HIV/STD Risk among Young Expectant Fathers: Relationship Attachment & Transition (Summer Supplement) Trace Kershaw, Ph.D. National Institute of Mental Health 06/01/2009 09/30/2010
286 HIV/STD Risk among Young Expectant Fathers: Relationship Attachment & Transition Trace Kershaw, Ph.D. National Institute of Mental Health 09/22/2006 07/31/2012 R01 Further Detail
287 HIV/AIDS Prevention and Treatment among Refugees and Forcibly Displaced Populations Kaveh Khoshnood, Ph.D., M.P.H. Yale MacMillan Center 07/01/2020 08/27/2022 Conference Support
288 HIV/AIDS Prevention and Treatment among Refugees and Forcibly Displaced Populations Luke Davis, M.D. Yale MacMillan Center 07/01/2020 08/27/2022 Conference Support
289 HIV/AIDS and the Disability: A Global Survey on HIV/AIDS on Disability Nora Ellen Groce, Ph.D. World Bank HIV/AIDS 01/15/2003 06/30/2004
290 HIV/AIDS and Disability in the Developing World: A Pilot Study in Swaziland Nora Ellen Groce, Ph.D. CIRA 02/12/2003 02/11/2006 CIRA Pilot
291 HIV, Buprenorphine, and the Criminal Justice System Frederick L Altice, M.D. National Institute on Drug Abuse 09/30/2010 06/30/2016 R01 Further Detail
292 HIV Transmission in Russia Through Liquid Drug Injection Robert Heimer, Ph.D. National Institute on Drug Abuse 09/30/2001 08/31/2006 R01 Further Detail
293 HIV Transmission Among Minority Children at Risk for Alcohol Related Problems Kathleen R. Merikangas, Ph.D. National Institute on Alcohol Abuse and Alcoholism 02/01/1995 01/31/2002 R01 Further Detail
294 HIV Testing and Treatment to Prevent Onward HIV Transmission among High-risk MSM National Institute on Drug Abuse 07/15/2011 04/30/2016 RO1 Further Detail
295 HIV Testing and Partner Notification Services for Women in China Cynthia X. Shi, M.Sc. National Institute of Mental Health 09/16/2018 09/15/2020 F31 Further Detail
296 HIV Testing and Behavior Change Christopher Udry, Ph.D. CIRA 06/25/2004 06/24/2006 CIRA Pilot
297 HIV Sex Risk Among Migrant Farmworkers in the Connecticut River Valley Michael Duke, Ph.D. CIRA 05/01/2000 07/31/2003 CIRA Pilot
298 HIV Prevention Trials Network (HPTN) Sten H. Vermund, M.D., Ph.D. National Institute of Allergy and Infectious Diseases 06/01/2009 11/30/2020 UM1 Further Detail
299 HIV Prevention Research with HIV+ Incarcerated Populations Frederick L Altice, M.D. National Center for HIV, Viral Hepatitis, STDs and TB Prevention 09/01/2006 08/31/2009 UR6 Further Detail
300 HIV Prevention Needs Among Unstably Housed Youth in Small Urban Areas Heather Mosher, Ph.D. NIMH through CIRA's Pilot Project Program 04/27/2015 04/26/2016 Pilot Project
301 HIV Prevention Needs Among MSM in Small Urban Areas Danya Keene, Ph.D. NIMH through CIRA's Pilot Project Program 06/09/2014 06/30/2015
302 HIV Prevention Needs Among MSM in Small Urban Areas John Pachankis, Ph.D. NIMH through CIRA's Pilot Project Program 06/09/2014 06/30/2015
303 HIV Prevention in High-Risk Drug Use Sites: Project RAP (Risk Avoidance Partnership) Margaret R. Weeks, Ph.D. National Institute on Drug Abuse 01/08/2000 07/19/2006 R01 Further Detail
304 HIV Oral Testing Infographic Experiment (HOTIE) S Raquel Ramos, FNP-BC, MBA, MSN, PhD National Institute of Mental Health 07/11/2017 07/10/2018 REIDS Pilot Project
305 HIV Co-morbidities Research Training in Ghana (HIV-COMRT) Elijah Paintsil, M.D. Fogarty International Center 06/15/2020 12/31/2024 D43 Further Detail
306 HIV Care and Treatment Collaborative Program in Russia Krystn Wagner, M.D., Ph.D. American International Health Alliance 07/01/2004 09/30/2006
307 HIV and Other Risks of the Transnational Commercial Sex Trade: Assessing Social and Cultural Factors CIRA 07/01/2003 06/30/2004
308 High-Risk Establishments and Women's HIV Prevention in Southern China Margaret R. Weeks, Ph.D. National Institute of Mental Health 02/01/2007 01/31/2013 R01 Further Detail
309 High Yield HIV testing, Facilitated Linkage to Care and Prevention for Female Youth in Kenya Ann Kurth, Ph.D., CNM, MPH National Institute of Allergy and Infectious Diseases 08/01/2015 07/31/2020 R01 Further Detail
310 High Risk Crack Use Settings and HIV in El Salvador Julia Dickson-Gomez, Ph.D. National Institute on Drug Abuse 09/20/2006 10/22/2007
311 HERO (Housing and Employment Resources to Improve HIV Outcomes) Health Resources and Services Administration (HRSA)
312 Guidelines for HIV/AIDS Interventions for People who are Deaf, Blind and Intellectually Disabled Nora Ellen Groce, Ph.D. World Health Organization 05/01/2006 12/31/2006
313 Georgian Implementation Science Fogarty Training Program (GIFT) Frederick L Altice, M.D. Fogarty International Center/National Institute on Drug Abuse 04/01/2023 03/31/2028 D43 Further Detail
314 Generating Knowledge for the Development of a Culturally Tailored Intergenerational Triad Intervention to Reduce Substance Abuse and Improve Psychological Wellness and HIV Outcomes in African American Women Living in the Deep South LaDrea Ingram, Ed.D., CHES Research Education Institute for Diverse Scholars (REIDS) 06/03/2019 06/02/2020 REIDS Pilot Project
315 Food Insecurity and HIV Prevention and Risk Reduction among Individuals Recently Released from Prison CIRA 12/01/2009 06/30/2011 CIRA Pilot
316 Female Condom Use in High-Risk Women as Predictor of Microbicide Readiness Margaret R. Weeks, Ph.D. Office of AIDS Research 09/01/2002 08/31/2003
317 Feasibility of a Multi-Sector Collaboration to initiate PrEP Uptake among IPV-Exposed Women Trace Kershaw, Ph.D. National Institute of Mental Health 05/17/2016 05/16/2017 CIRA Pilot Project
318 Faith-Based HIV Prevention Initiatives in Africa Kari Hartwig, Dr. P.H., M.A. Fogarty International Center 05/01/2002 04/30/2003
319 Facilitators and Barriers to Addressing Intimate Partner Violence in CT HIV/AIDS Services Agencies Nathan Hansen, Ph.D. CIRA 12/06/2010 12/05/2011 CRPP
320 Facilitators and Barriers to Addressing Intimate Partner Violence in CT HIV/AIDS Services Agencies CIRA 12/06/2010 12/05/2011 CRPP
321 Exploring Transgender Women’s Perceptions of E-Health Technology for Sexual Health Care Support Keosha T. Bond, Ed.D., M.P.H., CHES Research Education Institute for Diverse Scholars (REIDS) 05/06/2019 05/31/2020 REIDS Pilot Project
322 Exploring the Feasibility of a Peer-driven Intervention to Improve HIV Prevention Among Prisoners Who Inject Drugs Yulia Rozanova, Ph.D. National Institute On Drug Abuse 03/15/2019 02/29/2024 K01 Further Detail
323 Expansion and Integration of TB/HIV Care and Treatment in Rural KwaZulu Natal, South Africa Gerald H. Friedland, M.D. President's Emergency Program for AIDS Relief (PEPFAR) 05/01/2007 04/30/2009
324 Expanding Medication Assisted Therapies in Ukraine Frederick L Altice, M.D. National Institute on Drug Abuse 04/15/2012 03/31/2018 RO1 Further Detail
325 Examining Multilevel System Dynamics Affecting HIV Community Viral Load Margaret R. Weeks, Ph.D. National Institute of Mental Health 03/23/2015 01/31/2018 R01 Further Detail
326 Evaluations of Medication Assisted Treatments for Substance Use Disorders Among Persons Living with and at Risk for HIV Infection Sandra Ann Springer, M.D. National Institute on Drug Abuse 05/01/2018 04/30/2023 K02 Further Detail
327 Evaluation of Opt-Out HIV Screening in a Family Planning Setting CIRA 03/17/2011 03/16/2012 CRPP
328 Evaluation of Opt-Out HIV Screening in a Family Planning Setting Linda Niccolai, Ph.D. CIRA 03/17/2011 03/16/2012 CRPP
329 Evaluation of Innovative Methods for Integrating Buprenorphine Opioid Abuse Treatment in HIV Primary Care Setting David A. Fiellin, M.D. Health Resources and Services Administration 09/01/2004 08/31/2009
330 Evaluation of a Combined Motivational Interviewing and Ecological Momentary Intervention to Reduce Risky Alcohol Use among Sexual Minority Males and Transgender Individuals National Institute on Alcohol Abuse and Alcoholism 08/15/2022 05/31/2027 R01 Further Detail
331 Evaluation of a Combined Motivational Interviewing and Ecological Momentary Intervention to Reduce Risky Alcohol Use among Sexual Minority Males and Transgender Individuals Trace Kershaw, Ph.D. National Institute on Alcohol Abuse and Alcoholism 08/15/2022 05/31/2027 R01 Further Detail
332 Evaluating Violence against Women Screening in Mexico City Anonymous 01/01/2012 12/31/2014
333 Evaluating the Role of Opioid Medication Assisted Therapies in HIV-1 Persistence for Persons Living with HIV and Opioid Use Disorders Sandra Ann Springer, M.D. National Institute on Drug Abuse 09/01/2018 07/31/2021 R61 Further Detail
334 Evaluating the Link between HIV Prevention and Treatment National Institute of Mental Health 07/01/2002 08/31/2012 R01 Further Detail
335 Evaluating the Effects of Expanded Hours for Syringe Exchange Programs in Connecticut Robert Heimer, Ph.D. Gilead Foundation 09/01/2006 06/30/2008
336 Evaluating Health and Economic Effects of Targeted Strategies in TB/HIV Epidemics Ted Cohen, M.D.,M.P.H National Institute of Allergy and Infectious Diseases 07/01/2014 06/30/2018 RO1 Further Detail
337 Evaluating and Improving HIV Outcomes in Community-Based Women who Interface with the Criminal Justice System Jaimie Meyer, M.D., M.S., F.A.C.P. National Institute on Drug Abuse 07/01/2012 06/30/2017 K23 Further Detail
338 Estimating the Size of Hidden and Hard-to-Reach Populations using Respondent-driven Sampling Forrest W. Crawford, Ph.D. NIMH through CIRA's Pilot Project Program 02/20/2015 02/19/2016
339 Environmental Factors in HIV Transmission among Suburban IDUs (Diversity Supplement) Robert Heimer, Ph.D. National Institute on Drug Abuse 07/01/2009 06/30/2011 R01 Supplement
340 Environmental Factors in HIV Transmission among Suburban IDUs Robert Heimer, Ph.D. National Institute on Drug Abuse 07/01/2007 04/30/2012 R01 Further Detail
341 Enhancing Surveillance Systems to Slow the Spread of Antimicrobial-Resistant Gonorrhea in the United States Reza Yaesoubi, Ph.D. National Institute of Allergy and Infectious Diseases 06/23/2020 05/31/2025 R01 Further Detail
342 Enhancing HIV Prevention through a Multi-level Community Intervention to Promote Women-Initiated Prevention Options Margaret R. Weeks, Ph.D. National Institute of Mental Health 01/15/2009 12/31/2013 R01 Further Detail
343 Enhancing Health Outcomes with HIV+ Substance Abusers Frederick L Altice, M.D. National Institute on Drug Abuse 09/01/2008 07/31/2015 K24 Further Detail
344 Engaging Providers, Community Members, and Young Women to Adapt and Pilot a Youth-Friendly Sexual and Reproductive Health Package in Low-Income Communities in India Marie Brault, Ph.D. Fogarty International Center 09/04/2020 05/31/2024 K01 Further Detail
345 Efficacy Trial of a Brief Health Enhancement Intervention for Newly Diagnosed Men Nathan Hansen, Ph.D. National Institute of Mental Health 04/01/2012 03/31/2017 R01 Further Detail
346 Efficacy Trial of a Brief Health Enhancement Intervention for Newly Diagnosed Men National Institute of Mental Health 04/01/2012 03/31/2017 R01 Further Detail
347 Economic Evaluation of Drug Abuse Treatment and HIV Prevention Services for Pregnant Women National Institute on Drug Abuse 01/15/2009 12/31/2012 R01 Further Detail
348 Drug Use and AIDS Risk Patterns of Drug User Romantic Dyads Janie Simmons, Ed.D. CIRA 09/01/1999 03/01/2002 CIRA Pilot
349 Drug Policy, Incarceration, Community Re-entry, and Race Disparities in HIV/AIDS (SHARPP II) Kim M. Blankenship, Ph.D. National Institute on Drug Abuse 09/15/2009 07/31/2014 R01 Further Detail
350 Drug Policy in the Islamic Republic of Iran Kaveh Khoshnood, Ph.D., M.P.H. Yale Center for International and Area Studies 07/01/2004 12/31/2004
351 Drug Counseling and Abstinent-Contingent Take Home Buprenorphine in Malaysia Richard S Schottenfeld, M.D. National Institute on Drug Abuse 09/30/2001 08/31/2014 R01 Further Detail
352 Drinking Behaviors of Migrant and Non-Migrant Farmworkers Michael Duke, Ph.D. National Institute on Alcohol Abuse and Alcoholism 09/28/2001 06/30/2005 R01
353 Disparities in HPV Vaccine Completion: Identifying and Quantifying the Barriers Linda Niccolai, Ph.D. National Cancer Institute 12/01/2012 11/30/2015 R21 Further Detail
354 Directly Observed Therapy for Community-Released HIV+Prisoners Frederick L Altice, M.D. National Institute on Drug Abuse 09/01/2004 06/30/2010 R01 Further Detail
355 Development and Validation of a Novel and HIV-Relevant Prediction Model for Fracture Evelyn Hsieh, M.D., Ph.D. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS​) 04/01/2021 03/31/2026 R01 Further Detail
356 Development and testing of a mobile application to enhance HIV prevention cascade in Malaysian MSM Roman Shrestha, Ph.D., M.P.H. Fogarty International Center 09/11/2020 06/30/2022 R21 Further Detail
357 Development and Preliminary Trial of a Brief, Portable Health Intervention for Rural Sexual Minority Emerging Adults John Pachankis, Ph.D. National Institute of Mental Health 03/15/2017 02/28/2019 R21 Further Detail
358 Development and Implementation of a Spiritual Coping Intervention for Individuals with HIV Nalini Tarakeshwar, Ph.D. CIRA 01/01/2003 12/31/2005 CIRA Pilot
359 Development and Evaluation of a PrEP Decision Aid for Women Seeking Domestic Violence Services in Baltimore Tiara C. Willie, Ph.D. National Institute of Mental Health 08/11/2021 07/31/2024 R34 Further Detail
360 Development and Evaluation of a PrEP Decision Aid for Women Seeking Domestic Violence Services in Baltimore Jaimie Meyer, M.D., M.S., F.A.C.P. National Institute of Mental Health 08/11/2021 07/31/2024 R34 Further Detail
361 Developing social capital interventions to improve viral suppression and quality of life among HIV- positive aging populations in New Haven, CT Yusuf Ransome, MPH, DrPH National Institute of Mental Health 07/17/2019 07/16/2020 CIRA Pilot Project
362 Developing Internet-Delivered, Mindfulness-based Intervention to Reduce HIV Risk and Promote Mental and Sexual Health among Young Adult MSM Shufang Sun, Ph.D. National Center for Complementary & Integrative Health 09/01/2020 08/31/2025 K23 Further Detail
363 Developing efficient intervention technologies to reduce stigma related stress, mental health problems, and HIV risk among young Chinese MSM John Pachankis, Ph.D. Fogarty International Center 08/01/2020 06/30/2022 R21 Further Detail
364 Developing e-Covery: An App-Based Intervention to Support Recovery from Co-occurring Alcohol Use and Opioid Use Adam Viera, M.P.H. National Institute on Alcohol Abuse and Alcoholism 09/01/2020 08/31/2023 F31 Further Detail
365 Developing and validating a quantitative measure of daily intersectional stigma experiences for Black people with disabilities Katie Wang, Ph.D. National Institute on Minority Health and Health Disparities 09/23/2023 04/30/2026 R01 Further Detail
366 Developing an artificial intelligence-based mHealth intervention to increase HIV testing in Malaysia Zhao Ni, PhD, BMedSci, RN Fogarty International Center 09/11/2020 06/30/2022 R21 Further Detail
367 Developing an artificial intelligence-based mHealth intervention to increase HIV testing in Malaysia Frederick L Altice, M.D. Fogarty International Center 09/11/2020 06/30/2022 R21 Further Detail
368 Developing an Artificial Intelligence Chatbot to Promote HIV Testing Frederick L Altice, M.D. National Institute of Allergy and Infectious Diseases 06/16/2020 05/31/2022 R21 Further Detail
369 Developing a Social Marketing Campaign for Urban At-Risk Youth Kari Hartwig, Dr. P.H., M.A. CIRA 05/13/2005 05/12/2006 CRPP
370 Developing a Social Marketing Campaign for Urban At-Risk Youth CIRA 05/13/2005 05/12/2006 CRPP
371 Developing a Scientific and Methodological Center for Research and Facilitation Efficiency Improvement of Organizations Engaged in HIV Prevention in the Russian Federation Robert Heimer, Ph.D. U.S. Civilian Research and Development Foundation 06/15/2008 06/30/2010
372 Developing a Comprehensive Model of the HIV Care Continuum in Nine Small Cities in Connecticut, Massachusetts, and Rhode Island Lauretta Grau, Ph.D. National Institute of Mental Health 07/01/2015 04/30/2016 CIRA Pilot Project
373 Developing a Comprehensive Model of the HIV Care Continuum in Nine Small Cities in Connecticut, Massachusetts, and Rhode Island Thomas J. Stopka, Ph.D., M.H.S. National Institute of Mental Health 07/01/2015 04/30/2016 CIRA Pilot Project
374 Delineating host, parasite and pharmacologic factors impacting the treatment of malaria in children with and without HIV Sunil Parikh, M.D.,M.P.H Eunice Kennedy Shriver National Institute of Child Health and Human Development 09/07/2022 08/31/2024 R21 Further Detail
375 Culturing HIV in Denguele, Cote d'Ivoire: From the Ethnography of Illness and Healing To Performance Interventions With Local Networks of Hunter-Healers, Young Men, and Women Joseph Hellweg, Ph.D. CIRA 07/10/2002 12/30/2003 CIRA Pilot
376 Culturally Enhanced Trauma Treatment for African American Youth: Integrating Racial Socialization Isha Metzger, Ph.D. National Institute of Mental Health 07/11/2017 07/10/2018 REIDS Pilot Project
377 Cultural and Environmental Influences on Precursors to and Early Stages of Alcohol, Nicotine, and Cannabis Use in Black and Latinx Youth Carolyn Sartor, Ph.D. National Institute on Minority Health and Health Disparities 12/08/2021 11/30/2026 R01 Further Detail
378 Criminal Justice, Race, and HIV Risk in CT Drug Users Kim M. Blankenship, Ph.D. National Institute on Drug Abuse 09/25/2004 08/31/2007
379 Crack Use and Related Sexual Risk in El Salvador Julia Dickson-Gomez, Ph.D. CIRA 02/12/2003 02/11/2006 CIRA Pilot
380 Counseling for Primary Care Office-Based Buprenorphine David A. Fiellin, M.D. National Institute on Drug Abuse 08/20/2005 07/31/2011 R01 Further Detail
381 Coping with Pediatric HIV/AIDS in South Africa: Needs Assessment and Development of a Child Focused Psychosocial Intervention CIRA 06/20/2006 06/19/2008 CIRA Pilot
382 Coordinated Medical Treatment of Opioid Use Disorder and Infectious Disease Sandra Ann Springer, M.D. National Center for Advancing Translational Sciences 07/18/2019 06/30/2023 U01 Further Detail
383 Consortium to Improve Outcomes in HIV/AIDS, Alcohol, Aging and Multi-Substance Use (COMpAAAS) Amy C. Justice, M.D., M.Sc., Ph.D. National Institute on Alcohol Abuse and Alcoholism 09/01/2016 08/31/2019 U01 Further Detail
384 Connecting People, Places & Things: The Effect of these Connections on Adherence and Retention in HIV Care Interventions among HIV-infected Drug Users Debarchana (Debs) Ghosh, Ph.D. National Institute on Drug Abuse 08/01/2014 07/31/2019 K01 Further Detail
385 Connecticut Syringe Exchanges and Early Intervention Packages Lauretta Grau, Ph.D. Drug Policy Foundation 07/01/2000 06/30/2002
386 Confronting XDR TB and HIV in Rural South Africa (2nd) Gerald H. Friedland, M.D. Irene Diamond Fund 07/01/2008 12/31/2017
387 Confronting XDR TB and HIV in Rural South Africa Gerald H. Friedland, M.D. Gilead Foundation 01/01/2008 12/31/2011
388 Comprehensive Translational Science Analytics Tools for the Global Health Agenda Donna Spiegelman, Sc.D. National Institute of Environmental Health Sciences 09/15/2018 07/31/2019 DP1 Further Detail
389 Comprehensive Search of Research on Programs Targeted Towards the Disabled with AIDS or at Risk to AIDS Internationally Nora Ellen Groce, Ph.D. CIRA 05/10/2002 05/09/2003
390 Comprehensive Elementary School AIDS Education David J. Schonfeld, M.D. National Institute of Child Health and Human Development 09/01/1998 07/31/2003
391 Community-based Intensive Case Finding for HIV, TB, and MDR/XDR TB in Rural South Africa Sheela V. Shenoi, M.D.,M.P.H National Institute of Allergy and Infectious Diseases 05/15/2011 04/30/2016 K23 Further Detail
392 Community-based HIV Education Research Program for Diverse Scholars Trace Kershaw, Ph.D. National Institute of Mental Health 09/01/2010 08/31/2015 R25 Further Detail
393 Community-based HIV Education Research Program for Diverse Scholars Barbara Guthrie, Ph.D., R.N., FAAN National Institute of Mental Health 09/01/2010 08/31/2015 R25 Further Detail
394 Community-based HIV Education Research Program for Diverse Scholars Jean J. Schensul, Ph.D. National Institute of Mental Health 09/01/2010 08/31/2015 R25 Further Detail
395 Community Organizations in Syringe Exchange in Springfield, MA Susan Shaw, Ph.D. National Institute on Drug Abuse 06/01/2003 05/31/2005 R03 Further Detail
396 Community Organizations in Syringe Exchange in Springfield, MA National Institute on Drug Abuse 06/01/2003 05/31/2005 R03 Further Detail
397 Combating MDR and SDR TB and HIV in Rural South Africa Gerald H. Friedland, M.D. Doris Duke Foundation 02/02/2007 02/22/2009
398 CIRA/University of Pretoria South Africa Research Collaboration Project CIRA 03/14/2011 06/30/2011 CIRA Pilot
399 CIRA/St. Petersburg Research Collaborative Project Robert Heimer, Ph.D. CIRA 03/03/2011 06/30/2011 CIRA Pilot
400 Chronic Opioid Therapy and Patient Safety in HIV Infected and Uninfected Veterans Julie R. Gaither, R.N., M.P.H. National Institute on Drug Abuse 04/01/2013 03/31/2015 F31 Further Detail
401 China Multidisciplinary AIDS Prevention Training Program Kaveh Khoshnood, Ph.D., M.P.H. Fogarty International Center 07/01/2004 06/30/2009
402 Characterizing the Post-incarceration Risk Environment in St. Petersburg, Russia Javier Cepeda, M.P.H., Ph.D. National Institute on Drug Abuse 09/01/2013 06/30/2015 F31 Further Detail
403 Care Corrections: Technology for Jail HIV/HCV Testing, Linkage and Care (TLC) Curt G. Beckwith, M.D. National Institute on Drug Abuse 09/30/2010 06/30/2017 R01 Further Detail
404 Building Mobile HIV Prevention and Mental Health Support in Low-Resource Settings John Pachankis, Ph.D. National Institute of Mental Health 09/05/2018 06/30/2023 R01 Further Detail
405 Building Mobile Health HIV-Prevention Capacity for MSM in Romania John Pachankis, Ph.D. Fogarty International Center 09/10/2014 04/30/2016 R21 Further Detail
406 Building Community Responses to Risks of Emergent Drug Use Centers for Disease Control 09/30/2002 09/29/2005
407 Biopsychosocial Mechanisms Underlying Internalizing Psychopathology in a Prospective, Population-Based Cohort of Sexual Minority Young Adults John Pachankis, Ph.D. National Institute of Mental Health 03/01/2019 12/31/2023 R01 Further Detail
408 Barriers to Implementation of Isoniazid Prevention Therapy in Rural KwaZulu-Natal, South Africa Sheela V. Shenoi, M.D.,M.P.H NIMH through CIRA's Pilot Project Program 06/09/2014 06/30/2015
409 Barriers to HIV Care for Adults 50yo+, a Neglected but at-risk Population in Ukraine Sheela V. Shenoi, M.D.,M.P.H National Institute of Mental Health 01/29/2018 01/28/2019 CIRA Pilot Project
410 Barriers to HIV Care for Adults 50yo+, a Neglected but at-risk Population in Ukraine Yulia Rozanova, Ph.D. National Institute of Mental Health 01/29/2018 01/28/2019 CIRA Pilot Project
411 Avoiding Delay in ART Initiation in Rural South Africa Sheela V. Shenoi, M.D.,M.P.H Patterson Foundation 04/01/2014 09/30/2016 Further Detail
412 Assessing Local HIV Care Continuum Experiences in Small Cities Lauretta Grau, Ph.D. National Institute of Mental Health 01/29/2018 01/28/2019 CIRA Pilot Project
413 Assessing Local HIV Care Continuum Experiences in Small Cities Thomas J. Stopka, Ph.D., M.H.S. National Institute of Mental Health 01/29/2018 01/28/2019 CIRA Pilot Project
414 Assessing and Addressing Stigma towards PLWHA in Connecticut to Strengthen the Implementation of Evidence-Based Interventions Valerie Earnshaw, Ph.D. CIRA 10/16/2012 10/15/2013 Pilot Project
415 Assessing and Addressing Stigma towards PLWHA in Connecticut to Strengthen the Implementation of Evidence-Based Interventions CIRA 10/16/2012 10/15/2013 Pilot Project
416 Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons Michael J. Silverberg, Ph.D., M.P.H. National Cancer Institute 09/14/2012 06/30/2017 RO1 Further Detail
417 Antimalarial Pharmacology in HIV Coinfected Children and Pregnant Women in Uganda Sunil Parikh, M.D.,M.P.H NICHD/NIAID 12/23/2010 11/30/2016 R01 Further Detail
418 An mHealth implementation strategy to address the syndemic of mental illness, hypertension, and HIV in Uganda Jeremy I. Schwartz, M.D. National Institute of Mental Health 09/12/2023 08/31/2025 R21 Further Detail
419 An Interactive Video Game for HIV Prevention in At-Risk Adolescents Lynn E. Fiellin, M.D. National Institute of Child Health and Human Development 08/10/2009 07/31/2016 R01 Further Detail
420 An Analysis and Comparison of Cross-Border Populations Related to the HIV Epidemic in Three Regions of China Ann B. Williams, R.N.C., Ed.D. CIRA 03/15/2005 03/14/2006
421 An Accessible Digital Intervention to Promote HIV Testing/Counseling and Prevention Among Adolescents Jesse N Schell National Institute of Child Health and Human Development 05/01/2016 08/31/2019 R42 Further Detail
422 An Accessible Digital Intervention to Promote HIV Testing/Counseling and Prevention Among Adolescents Lynn E. Fiellin, M.D. National Institute of Child Health and Human Development 05/01/2016 08/31/2019 R42 Further Detail
423 Alcohol Pharmacotherapies Among Released Prisoners Frederick L Altice, M.D. National Institute on Alcohol Abuse and Alcoholism 09/30/2009 08/31/2014 R01 Further Detail
424 Alcohol Pharmacotherapies Among Released Prisoners Sandra Ann Springer, M.D. National Institute on Alcohol Abuse and Alcoholism 09/30/2009 08/31/2014 R01 Further Detail
425 Alcohol Associated Outcomes among HIV+/- Aging Veterans Amy C. Justice, M.D., M.Sc., Ph.D. National Institute on Alcohol Abuse and Alcoholism 09/30/2006 08/31/2012 U10 Further Detail
426 Alcohol and Multisubstance Use in the Veterans Aging Cohort Study Amy C. Justice, M.D., M.Sc., Ph.D. National Institute on Alcohol Abuse and Alcoholism 09/10/2011 08/31/2016 U01 Further Detail
427 Alcohol and HIV Risk Reduction in St. Petersburg, Russian Federation National Institute on Alcohol Abuse and Alcoholism 09/30/2007 06/30/2013 R01 Further Detail
428 Alcohol & HIV in Kenya: Stage 1 Trial of a Peer-led Alcohol Behavior Intervention Rebecca Papas, Ph.D. National Institute on Alcohol Abuse and Alcoholism 07/10/2007 06/30/2009 R21
429 AIDS International Training and Research Program Supplement: SPSU PH Educational Program Fogarty International Center 09/30/1998 05/31/2009
430 AIDS International Training and Research Program Supplement to India Michael H. Merson, M.D. Fogarty International Center 10/01/1999 05/31/2004
431 Adult, Aware, and Alive Lauretta Grau, Ph.D. CIRA 06/08/2006 06/07/2007 CRPP
432 Adult, Aware, and Alive CIRA 06/08/2006 06/07/2007 CRPP
433 Administrative Supplement to TB-AIDS ICOHRTA Robert Heimer, Ph.D. Fogarty International Center/National Institute on Drug Abuse 04/01/2005 03/31/2007
434 Administrative Supplement to Establish an NIH/FIC Alumni Association in Russia Fogarty International Center/ National Institute of Environmental Health Sciences 09/30/1998 05/31/2010 D43 Supplement
435 Addressing Social Emotions to Encourage STD Prevention Behaviors, the Wear It! Project Loraine Devos-Comby, Ph.D. CIRA 07/01/2001 07/31/2002 CIRA Pilot
436 Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations Sandra Ann Springer, M.D. National Institute on Drug Abuse 09/30/2020 07/31/2025 U01 Further Detail
437 Addressing HIV Risk in Young Unhealthy Alcohol Drinkers in the Emergency Department with Rapid HIV Testing and Brief Intervention Lynn E. Fiellin, M.D. CIRA 09/21/2009 06/30/2011 CIRA Pilot
438 Addressing Disparities in HIV Testing and Care among Displaced MSM Robert Heimer, Ph.D. National Institute of Child Health and Human Development 06/22/2017 03/31/2019 R21 Further Detail
439 Addressing Adherence to PMTCT and Early Care of Women and Infants in South Africa National Institute of Mental Health 08/05/2009 07/31/2012 R21 Further Detail
440 Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings Frederick L Altice, M.D. National Institute on Drug Abuse 08/15/2016 04/30/2021 R01 Further Detail
441 Adapting Peer Navigation for Out-of-Care Older Persons with HIV in Ukraine Yulia Rozanova, Ph.D. National Institute on Aging 06/15/2021 05/31/2023 R21 Further Detail
442 Adapting Peer Navigation for Out-of-Care Older Persons with HIV in Ukraine Sheela V. Shenoi, M.D.,M.P.H National Institute on Aging 06/15/2021 05/31/2023 R21 Further Detail
443 Adapting and coping during the war in Ukraine: lived experiences of older adults with HIV and their healthcare providers Yulia Rozanova, Ph.D. National Institute on Aging 06/15/2021 05/31/2023 R21 Further Detail
444 Adapting and coping during the war in Ukraine: lived experiences of older adults with HIV and their healthcare providers Sheela V. Shenoi, M.D.,M.P.H National Institute on Aging 06/15/2021 05/31/2023 R21 Further Detail
445 Adapting an evidence-based intervention for stigma-related stress, mental health, and HIV risk for MSM of color in small urban areas John Pachankis, Ph.D. National Institute of Mental Health 02/12/2018 02/11/2019 CIRA Pilot Project
446 Adapting an evidence-based intervention for stigma-related stress, mental health, and HIV risk for MSM of color in small urban areas Krystn Wagner, M.D., Ph.D. National Institute of Mental Health 02/12/2018 02/11/2019 CIRA Pilot Project
447 Adapting a disclosure decision-aid to improve HIV outcomes for older adults in Ukraine Yulia Rozanova, Ph.D. National Institute of Mental Health 09/01/2022 07/31/2025 R34 Further Detail
448 Acupuncture and Coping Skills Training for Cocaine Abuse Arthur Margolin, Ph.D. National Institute on Drug Abuse 09/15/2000 06/30/2006
449 Access to ARV Therapy and Stigma: The Perceived Magnitude, Impact, and Implications of Stigma for HIV/AIDS Prevention Interventions among Women in Kenya Erica Dawson, Ph.D. CIRA 04/01/2006 03/31/2008 CIRA Pilot
450 Acceptance, Clinical Usefulness and Specificity of Rapid HIV Tests for Women in Late Pregnancy and Labor CIRA 09/01/1999 06/30/2001 CIRA Pilot
451 A unified protocol to address sexual minority women's minority stress, mental health and hazardous drinking John Pachankis, Ph.D. National Institute on Alcohol Abuse and Alcoholism 09/12/2022 08/31/2027 R01 Further Detail
452 A Unified Intervention for Young Gay and Bisexual Men’s Minority Stress, Mental Health, and HIV Risk John Pachankis, Ph.D. National Institute of Mental Health 02/15/2016 12/31/2020 R01 Further Detail
453 A Theory-informed Education and Counseling Intervention for HIV-TB Treatment Adherence (TEACH) in South Africa and Uganda Luke Davis, M.D. National Institute of Mental Health CIRA Pilot Project
454 A Theory-informed Education and Counseling Intervention for HIV-TB Treatment Adherence (TEACH) in South Africa and Uganda Sheela V. Shenoi, M.D.,M.P.H National Institute of Mental Health CIRA Pilot Project
455 A Study of Assisted HIV Self-Testing and Linkage to Care among Partners of People Living with HIV (PLHIV) in San Juan, Puerto Rico Trace Kershaw, Ph.D. National Institute of Mental Health 02/15/2022 02/14/2023 P30 EHE Supplement Grant
456 A Study of Assisted HIV Self-Testing and Linkage to Care among Partners of People Living with HIV (PLHIV) in San Juan, Puerto Rico Carmen Zorrilla, M.D. National Institute of Mental Health 02/15/2022 02/14/2023 P30 EHE Supplement Grant
457 A Smart Approach to Treating Tobacco Use Disorder in Persons Living with HIV E. Jennifer Edelman, MD, MHS, BS National Cancer Institute 09/19/2019 08/31/2024 R01 Further Detail
458 A Randomized Trial of Enhanced Nursing Telephone Support to Improve Medication Self-Management and Viral Outcomes of Antiretroviral Therapy-Experienced Patients Nancy Reynolds, R.N, Ph.D., F.A.A.N. National Institute of Allergy and Infectious Disease 06/29/2006 05/31/2013
459 A Qualitative and Quantitative Analysis of Perceived Risk of HIV Gary J. Burkholder Jr., Ph.D. CIRA 03/01/2001 08/31/2002 CIRA Pilot
460 A Pilot Study of Mandatory HIV Counseling and Voluntary Testing of Pregnant Women in Urumqui, the Capital City of Xinjiang in China Michael H. Merson, M.D. World AIDS Foundation 01/01/2001 08/31/2002
461 A Pilot HIV/AIDS Intervention for Crack Users in New Haven Kaveh Khoshnood, Ph.D., M.P.H. CIRA 09/01/2002 08/31/2004 CIRA Pilot
462 A Digital Intervention to Prevent the Initiation of Opioid Misuse in Adolescents in School-Based Health Centers Lynn E. Fiellin, M.D. National Institute on Drug Abuse 09/30/2019 08/31/2021 UG3 Further Detail
463 A Digital Intervention for HIV Prevention in Black Adolescent Girls Kimberly Hieftje, Ph.D. Eunice Kennedy Shriver National Institute of Child Health and Human Development 09/01/2019 08/31/2021 R21 Further Detail
464 A Cross-Cultural Analysis of the Role of Families in Harm Reduction Kaveh Khoshnood, Ph.D., M.P.H. CIRA 11/07/2002 11/06/2003
465 A Couple-based Relationship Strengthening HIV Intervention for Young Parents Trace Kershaw, Ph.D. National Institute of Mental Health 07/16/2011 06/30/2014 R34 Further Detail
466 A Computer Simulation of the Sub-Saharan HIV Pandemic Scott Braithwaite, M.D., M.Sc. National Institute on Alcohol Abuse and Alcoholism 09/30/2007 02/28/2013 R01 Further Detail
467 A Community Based HIV/STI Intervention for Pregnant Women in Haiti Trace Kershaw, Ph.D. CIRA 06/01/2003 06/30/2006 CIRA Pilot
468 A bioecological pediatric HIV disclosure intervention in Ghana - "SANKOFA" Elijah Paintsil, M.D. National Institute of Child Health & Human Development 09/01/2012 06/30/2017 R01 Further Detail
469 A bioecological pediatric HIV disclosure intervention in Ghana - "SANKOFA" Nancy Reynolds, R.N, Ph.D., F.A.A.N. National Institute of Child Health & Human Development 09/01/2012 06/30/2017 R01 Further Detail
470 A Feasibility Study on Non-Occupational HIV Post-Exposure the Emergency Department Setting Gail D'Onofrio, M.D. CIRA 07/01/2000 07/01/2001 CIRA Pilot
471 (PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer Amy C. Justice, M.D., M.Sc., Ph.D. National Cancer Institute 07/01/2016 05/31/2021 R01 Further Detail
472 "Doctoring": Assisted Injection Practices Among Injection Drug Users Sarah Brothers, Ph.D. National Science Foundation 09/01/2016 08/31/2019 Fellowship Further Detail
473 Training in mHealth Prevention with MSM Roman Shrestha, Ph.D., M.P.H. National Institute on Drug Abuse 07/15/2020 06/30/2025 K01 Further Detail